Inaba et al., 1996 - Google Patents
Reversible suppression of pituitary-testicular function by a sustained-release formulation of a GnRH agonist (leuprolide acetate) in dogsInaba et al., 1996
- Document ID
- 2109364956889801735
- Author
- Inaba T
- Umehara T
- Mori J
- Torii R
- Tamada H
- Sawada T
- Publication year
- Publication venue
- Theriogenology
External Links
Snippet
Pituitary-testicular function was studied in 15 dogs following treatment with a sustained- release formulation of a GnRH agonist, leuprolide acetate (LA). Adult male dogs were treated with a single subcutaneous injection of microencapsulated LA (0.1 or 1 mg/kg) …
- 241000282472 Canis lupus familiaris 0 title abstract description 31
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| King et al. | Relationships between protein intake during lactation, LH levels and oestrous activity in first-litter sows | |
| D'Occhio et al. | Reproductive responses of cattle to GnRH agonists | |
| Cook et al. | Secretory patterns of LH and FSH during development and hypothalamic and hypophysial characteristics following development of steroid-induced ovarian follicular cysts in dairy cattle | |
| Goericke‐Pesch et al. | Suppression of fertility in adult cats | |
| Rae et al. | Maternal undernutrition alters triiodothyronine concentrations and pituitary response to GnRH in fetal sheep | |
| Martins et al. | Effect of progesterone concentrations, follicle diameter, timing of artificial insemination, and ovulatory stimulus on pregnancy rate to synchronized artificial insemination in postpubertal Nellore heifers | |
| Estienne et al. | Effects of PG 600 on the onset of estrus and ovulation rate in gilts treated with Regu-mate | |
| Lindsay et al. | Nutrition and reproduction | |
| Almeida et al. | Effects of different patterns of feed restriction and insulin treatment during the luteal phase on reproductive, metabolic, and endocrine parameters in cyclic gilts | |
| Staigmiller et al. | Effect of nutrition on response to exogenous FSH in beef cattle | |
| Inaba et al. | Reversible suppression of pituitary-testicular function by a sustained-release formulation of a GnRH agonist (leuprolide acetate) in dogs | |
| Scoggin et al. | Strategies to improve the ovarian response to equine pituitary extract in cyclic mares | |
| Estienne et al. | Effect of exogenous gonadotropins on the weaning-to-estrus interval in sows | |
| Jabbour et al. | Effects of season, GnRH administration and lupin supplementation on the ovarian and endocrine responses of merino ewes treated with PMSG and FSH-P to induce superovulation | |
| Barrier-Battut et al. | Use of buserelin to induce ovulation in the cyclic mare | |
| McGrath et al. | Kisspeptin stimulates LH secretion but not ovulation in mares during vernal transition | |
| Pelican et al. | Priming with progestin, but not GnRH antagonist, induces a consistent endocrine response to exogenous gonadotropins in induced and spontaneously ovulating cats | |
| CA2224912C (en) | Method for promoting ovulation, parturition, and lactation in mammals | |
| Sianangama et al. | Effect of hCG administration on day 7 of the estrous cycle on follicular dynamics and cycle length in cows | |
| Sesti et al. | Secretion of gonadotropins and estimated releasable pools of gonadotropin-releasing hormone and gonadotropins during establishment of suckling-induced inhibition of gonadotropin secretion in the sow | |
| Dziuk et al. | Follicle growth and control of ovulation in the ewe following treatment with 6-methyl-17-acetoxyprogesterone | |
| Ritar et al. | Ovulatory activity, hormonal induction of ovulation and fertility of young Cashmere and Angora female goats in a temperate environment | |
| Oberhaus et al. | Factors affecting the ovarian response to a combined estradiol-sulpiride treatment in seasonally anovulatory mares | |
| Hurtgen et al. | Use of PMSG in the prevention of seasonal post-weaning anestrus in sows | |
| Misztal et al. | Central estrogen-like effect of genistein on growth hormone secretion in the ewe |